Dermatology

>

Latest News

Upadacitinib achieves 50% reduction in Total Vitiligo Area Scoring Index at 48 weeks | Image Credit: © Liga Cerina - © Liga Cerina - stock.adobe.com.
Upadacitinib achieves 50% reduction in Total Vitiligo Area Scoring Index at 48 weeks

October 29th 2025

Baricitinib demonstrates sustained hair regrowth in adolescents with alopecia areata | Image Credit: © Alex Papp - © Alex Papp - stock.adobe.com.
Baricitinib demonstrates sustained hair regrowth in adolescents with alopecia areata

October 24th 2025

Fall Clinical: Lebrikizumab-lbkz shows sustained skin clearance with one dose every 8 weeks | Image Credit: © arhat - © arhat - stock.adobe.com.
Fall Clinical: Lebrikizumab-lbkz shows sustained skin clearance with one dose every 8 weeks

October 24th 2025

Fall Clinical: Roflumilast creams 0.15%, 0.05% reduce sleep disruptions in AD patients 2 years, older | Image Credit: © Gorodenkoff  - © Gorodenkoff - stock.adobe.com.
Fall Clinical: Roflumilast creams 0.15%, 0.05% reduce sleep disruptions in AD patients 2 years, older

October 24th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.